Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Opko Health Inc. (OPK:NASDAQ), powered by AI.
Opko Health Inc. is currently trading at $1.39. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Opko Health Inc. on Alpha Lenz.
Opko Health Inc.'s P/E ratio is -4.6.
“Opko Health Inc. trades at a P/E of -4.6 (undervalued) with modest ROE of -17.1%.”
Ask for details →Opko Health Inc. is a diversified healthcare company that operates in the pharmaceutical and diagnostics sectors. The company's primary mission is to achieve significant advances in diagnosing and treating complex medical conditions. With a robust portfolio, Opko Health engages in the development and commercialization of specialty pharmaceuticals across various therapeutic areas, including endocrinology, oncology, and infectious diseases. In the diagnostics segment, Opko provides innovative solutions and services aimed at improving patient outcomes through early detection of diseases and individualized treatment plans. A notable feature of Opko Health is its strong emphasis on research and development, partnering with biotechnology firms and leveraging cutting-edge technology to bring novel healthcare solutions to market. Operating both in the United States and internationally, Opko's influence extends across the medical landscape as it strives to enhance healthcare delivery and access. Through its multifaceted operations, the company plays a pivotal role in pushing the boundaries of medical science and improving patient care on a global scale.
“Opko Health Inc. trades at a P/E of -4.6 (undervalued) with modest ROE of -17.1%.”
Ask for details →Opko Health Inc. (ticker: OPK) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 2,997 employees. Market cap is $1.0B.
The current price is $1.39 with a P/E ratio of -4.63x and P/B of 0.82x.
ROE is -17.14% and operating margin is -36.08%. Annual revenue is $607M.